Adam Simpson

Adam Simpson

President bij Dorado Ventures LLC

49 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Adam K.
Simpson
founded Meritage Pharma, Inc. Mr. Simpson is President for Dorado Ventures LLC.
He is also on the board of the University of California San Diego and Stratify Genomics, Inc. He previously was Attorney at Latham & Watkins LLP, Secretary, Vice President & General Counsel at Verus Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Pvp Biologics, Inc., President, Chief Executive Officer & Director at Icosavax, Inc., President & Chief Operating Officer at Cypher Genomics, Inc. and Secretary, Treasurer & Chief Business Officer at Meritage Pharma, Inc. Adam K.
Simpson
received an undergraduate degree from the University of California San Diego and a graduate degree from the University of Minnesota.

Actieve functies van Adam Simpson

BedrijvenFunctieBegin
University of California San Diego Director/Board Member -
Director/Board Member -
Dorado Ventures LLC President 01-01-2012
Alle actieve functies van Adam Simpson

Eerdere bekende functies van Adam Simpson

BedrijvenFunctieEinde
ICOSAVAX, INC. Chief Executive Officer 19-02-2024
Chief Executive Officer 01-02-2020
President 01-01-2015
Founder 01-01-2012
General Counsel 01-01-2008
Ervaring van Adam Simpson in detail bekijken

Opleiding van Adam Simpson

University of California San Diego Undergraduate Degree
University of Minnesota Graduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Adam Simpson in detail bekijken

Connecties

100 +

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit8

Health Technology

Health Technology

Commercial Services

Technology Services

Health Technology

Health Services

Health Technology

Dorado Ventures LLC

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Adam Simpson
Ontdek onze gratis inhoud om de beurs beter te leren begrijpen.
Gratis inschrijven
fermer